Tags
arthroplasty, Cohort study, England, England and Wales, Health, hip arthroplasty, Hip Replacement, orthopaedic surgery, osteoarthritis, personal bias, Research, science, surgery, Wales
Re: Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study | BMJ.
Related articles
- The Journal of Bone & Joint Surgery | Article (earlsview.com)
- Revision of hip resurfacing arthroplasty with a bone-conserving short-stem implant (earlsview.com)
- Moving Toward Sex-Specific Surgery? The Journal of Bone & Joint Surgery | Article (earlsview.com)
- MRI Findings in Painful Metal-on-Metal H… [AJR Am J Roentgenol. 2012] – PubMed – NCBI (earlsview.com)
- Jumbo cup in revision hip arthroplasty 53 cases with 84 months of follow-up – Orthopaedia Proceedings – Orthopaedia (earlsview.com)
- Hip Replacement – Arthroplasty wound complications linked to oral anticoagulant use (earlsview.com)
- Prediction of Functional Outcome at Six Months Following Total Hip Arthroplasty (earlsview.com)
- Hip resurfacing ‘not suitable’ for women – Health – Beverley Guardian (earlsview.com)
- Smith & Nephew BHR – A benign psoas mass following metal-on-metal resurfacing of the hip (earlsview.com)
- SCARY – Study finds elevated levels of cobalt and chromium in offspring of patients with metal-on-metal hip implants (earlsview.com)
Pingback: Australian Joint Registry Results – 2012 – MUST READ « Earl's View
Pingback: ‘Short stay’ hip arthroplasty patients show good results | Orthopedics « Earl's View
Pingback: Australia – Walking wounded: many unaware of faulty implants « Earl's View
Pingback: Age and gender affect risk of hip replacement revision surgery | Arthritis Research UK « Earl's View
Pingback: Changing Transfusion Practice in Total Hip Arthroplasty: Observational Study of the Reduction of Blood Use Over 6 Years | Orthopedics « Earl's View
Pingback: Leg-Length Discrepancy After Revision Hip Arthroplasty: Are Modular Stems Superior? « Earl's View
Pingback: Metal on Metal Expert Hip Resurfacing – Tom Joyce on device regulation | BMJ « Earl's View